InsiderTrades

Form 4 for AMPH Amphastar Pharmaceuticals, Inc.

Accepted 2024-12-16 00:00:00 ET · period of report 2024-12-12 · accession 0001415889-24-029491 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-12-16 2024-12-12+ AMPH Zhou Rong SENIOR EVP, PRODUCTION CENTER M - OptEx $11.33 +15.0K 125.5K +14% +$169.9K
DM 2024-12-16 2024-12-12+ AMPH Zhou Rong SENIOR EVP, PRODUCTION CENTER S - Sale+OE $44.86 -15.0K 118.5K -11% -$672.9K
DM 2024-12-16 2024-12-12+ AMPH Zhou Rong SENIOR EVP, PRODUCTION CENTER M - OptEx $0.00 -15.0K 17.8K -46% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-12-13 M A 8,000 $11.33 126,469 D — —
2 Common Common Stock 2024-12-13 S D 8,000 $45.23 118,469 D — —
3 Common Common Stock 2024-12-12 M A 7,000 $11.33 125,469 D — — (F1) Includes 81 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on November 30, 2024.
4 Common Common Stock 2024-12-12 S D 7,000 $44.43 118,469 D — —
5 Derivative Employee Stock Option (right to buy) 2024-12-13 M D 8,000 $0.00 9,787 D $11.33 · — to 2026-03-17 8,000 Common Stock (F4) Shares subject to the option are fully vested and immediately exercisable.
6 Derivative Employee Stock Option (right to buy) 2024-12-12 M D 7,000 $0.00 17,787 D $11.33 · — to 2026-03-17 7,000 Common Stock (F4) Shares subject to the option are fully vested and immediately exercisable.